The Baltimore Convention Center is now operating an outpatient infusion Center to administer monoclonal antibody therapies, approved by the Federal Drug Administration (FDA) under an Emergency Use Authorization (EUA).

The monoclonal antibody therapies offered at the BCC COVID Infusion Center include:

  • Bamlanivimab (manufactured by Eli Lilly)
  • A combination of casirivimab and imdevimab, administered simultaneously (more widely known as Regeneron, the manufacturer of these treatments)

Hours: The COVID Infusion Center is open Monday through Saturday, 8 am – 6 pm.

For Referring Providers

NEW REFERRAL PROCESS: To refer a patient for treatment to the Baltimore Convention Center COVID Infusion Center, outpatient providers should complete this Infusion Center online referral form.

The Baltimore Convention Center Infusion Suite team will review the referral form upon receipt and contact the patient to coordinate services as soon as possible. Please do not call or request preferential treatment as the team will triage and work to meet the needs of the patient with the limited dosing available.

Both treatments have the same FDA Emergency Use Authorization (EUA) criteria and have been demonstrated to reduce COVID-19 hospitalization or emergency room visits when administered within 10 days of symptom onset.

Referring providers should reference these Provider Fact Sheets:

Referring providers should understand that the allocation methodology is based on duration of symptom onset (longest to be prioritized). There is no further risk stratification based on other clinical characteristics at this point.

Which treatment is administered will be chosen based on availability and logistics.

Additionally, there is a chance that a patient's clinical condition may change in the time between referral and arrival to the infusion center. A patient may no longer be eligible. If demand exceeds supply of the drug or the capacity of the COVID Infusion Center, a lottery system will be applied. We urge providers to discuss this with patients and help manage their expectations.

For Patients

Only eligible patients who have been referred by a provider and then approved to receive the treatment will be contacted for scheduling. Please see BCC COVID Infusion Center Patient Information.

Jointly operated by:

Logos for Johns Hopkins Medicine and University of Maryland Medical System